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Abstract
Background: Regional variations in size and parenchyma echo-texture of  the spleen among sickle cell disease (SCD) pa-
tients have been documented in various publications. The objectives of  this study were to assess the size and parenchyma 
echo-texture of  the spleen of  SCD patients and ascertain the relationship of  age, height and weight with the spleen sizes.       
Methods: This was a cross sectional study involving 103 each of  SCD and age matched control subjects. Aloka ST- 550 - 
3500 ultrasound machine with 3.5 and 5 MHz convex transducers was used to scan the subjects over a 15 months period 
(September, 2012 to November, 2013). The age, height and weight of  each subject were recorded.
Results: The spleen sizes of  SCD patients were generally larger than those of  the controls (p < 0.05). Abnormal spleen 
parenchyma of  varied appearances was found among the SCD subjects. There were negative correlations between mean 
spleen sizes and height, weight and age in SCD patients but positive correlations were found between them in the controls. 
Conclusion: Routine sonographic assessment of  spleen size and echo-texture is useful in the management of  SCD patients. 
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Haemoglobinopathy is a genetic disorder including 
sickle cell disease (SCD) and thalassaemia.     Sickle cell 
disease is a qualitative genetic disorder in which there 
is alteration in the normal globin chain, while thalas-
saemia refers to a quantitative haemoglobin disorder in 
which there is reduced or even absent synthesis of  nor-
mal globin chains.1-4 Sickle cell disease is an autosomal 
recessive genetic disorder of  the blood characterized 
by red blood cells (RBCs) that assume abnormal, rigid 
and sickle shapes. This condition stimulates high blood 
viscosity, low oxygen affinity in RBCs, vaso-occlusions 
especially the tiny blood vessels, ischaemias, acute pains, 
infarctions and fibrosis of  dependant tissues.1,3,5 It is as-
sociated with pathologic consequences of  chronic and 
life-long illnesses.  Patients with SCD often have differ-
ent forms of  sickle cell crises.1,4 Sickle cell disease is a 
common genetic condition that is globally wide-spread 
and particularly common among people from sub-Sa-
haran Africa, India, Saudi Arabia, and Mediterranean 
countries.1
 
Each year about 300,000 infants are born with sickle 
cell disease globally, out of  which about 200,000 cas-
es occur in Africa, and 150,000 of  these SCD children 
are born annually in Nigeria alone.4 About 5% of  the 
world’s population carry genes responsible for SCD. 
The frequency of  sickle cell trait in West African coun-
tries like Ghana and Nigeria is 15% to 30%.6 Sickle cell 
gene is common in Africa because the sickle cell trait 
confers some resistance to falciparum malaria infection 
during the critical period of  early childhood. The fre-
quency of  the carrier state determines the prevalence 
of  SCD at birth.6 Only the inheritance of  a single ab-
normal gene - sickle cell trait - offers protection against 
malaria. Inheritance of  two abnormal genes (sickle cell 
disease) confers no such protection. Hence, malaria is 
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a major cause of  ill-health and death in children with 
SCD.1,4,6 
Sickle cell disease contributes the equivalent of  
5% of  under-five deaths on the African continent, 
more than 9% in West Africa, and up to 16% of  un-
der-five deaths in individual West African countries 
like Nigeria.4,6 Half  of  those with SCD usually die by 
the age of  5 years in sub-Saharan Africa from infec-
tions such as malaria, pneumococcal sepsis, and anae-
mia.4,6                                                                                                                                                                                     
 
Spleen is the most affected organ in SCD, because it 
receives the insults of  the associated clinical condi-
tions of  this pathology earlier than the other vulnerable 
body organs such as the liver, gallbladder, kidneys and 
bone marrow.7,8 This is due to its peculiar anatomy and 
physiology - it has narrow blood vessels and filters the 
systemic blood.7-9 There is a need to develop models 
of  care appropriate to the management of  sickle cell 
disease in sub-Saharan Africa which will be based on 
constant monitoring, early detection of  crises, and early 
presentation to the specialist treatment centers.6 Early 
monitoring and detection are enhanced by ultrasonog-
raphy of  the spleen because the spleen responds to 
different pathologic states such as fever and sickle cell 
disease by dimensional and parenchyma changes.10,11 Re-
gional variations in splenic size and spleen parenchyma 
echo-texture among sickle cell disease (SCD) patients 
exist in different publications.12-16   No such study has 
been documented in our locality.  
This study was, therefore, aimed at assessing the size 
and parenchyma echo- texture of  the spleen of  SCD 
patients and the relationship of  age, height and weight 
with the spleen size in a Nigerian population. The infor-
mation from this study will add to the pool of  knowl-
edge on SCD and in the management of  such patients 
in our center.
    
Patients and methods 
This is a cross-sectional prospective study conducted 
over a 15 month period (September, 2012 to Novem-
ber, 2013) at the University of  Nigeria Teaching Hos-
pital (UNTH), Enugu. Ethical approval was obtained 
from the Hospital's Research and Health Ethics Com-
mittee, and informed consent was obtained from the 
SCD subjects and controls or their care-givers prior to 
the study.
Convenience sampling technique was used to recruit 
103 stable SCD patients from sickle cell disease clinic 
of  UNTH, Enugu and 103 healthy age matched control 
subjects.   The controls were recruited from apparent-
ly healthy, normal genotype, patients on referrals from 
general outpatient department to radiation medicine 
department of  UNTH, Enugu for routine abdominal 
sonography. The subjects were aged 2-58 years. 
Inclusion criteria 
The study subjects (SCD and control subjects) were 
confirmed to have either HbSS/HbSC  or HbAA gen-
otype, were negative for malaria and typhoid disease, 
with no history of  surgical splenectomy nor any other 
surgery in the last one year. The controls had no history 
of  blood transfusion and no chronic or acute ailment 
of  recurrent nature; while SCD subjects had no crisis in 
the past three months prior to the study.
Exclusion criteria 
Pregnant and breast feeding mothers, and female sub-
jects that had abortion in the previous six months were 
excluded from the study. 
Equipment  
Aloka ST-550 – 3500 (Hannover, Germany) real time 
ultrasound machine with 3.5 MHz and 5 MHz curvi-
linear probes was used to scan the study groups. The 
ultrasound machine was validated for quality perfor-
mance by the departmental medical physicist prior to 
the measurements. Using the available freeze-frame ca-
pability, all the sonographic measurements were made 
with curvilinear probes using the electronic calipers. 
Demographic data was collected on each participant at 
the time of  their pre-participation physical examination. 
This information included age, sex, height and body 
weight. The age of  each subject was obtained from his 
/ her hospital birth certificate. Anthropometric meas-
urements were obtained on the participants wearing 
light weight street clothes without shoes. Weight was 
measured on a calibrated portable Salter scale (BR 
9011; Hana Co. Ltd, China) to the nearest 0.1kg. Height 
was measured with a metal tape measure to the nearest 
0.5cm with the participants standing upright with the 
head in the Frankfurt position.
 
Scanning technique
The technique of  right lateral decubitus position in the 
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coronal plane was adopted for this study because of  
superior advantage of  obtaining easily the longest di-
mension of  the spleen and reproducibility of  measure-
ment14. Longitudinal size measurement was performed 
between the most superomedial and the most inferolat-
eral points of  the spleen. The transverse dimension was 
measured between the hilum and the most superolateral 
margin of  the spleen. The choice of  probe depends on 
the age and physique of  the subjects. For instance, the 
3.5 MHz probe was predominantly used for imaging 
subjects aged 15 years and above and for overweight 
children from 12 to 14 years of  age whereas the 5 MHz 
probe was predominantly used for imaging slim chil-
dren below 15 years of  age and very thin adult SCD 
patients.
A subgroup of  twenty five participants underwent three 
ultrasound scans of  the spleen done two days apart by 
three different sonographers to determine intra- and 
inter rater reliability of  spleen size measurements (pilot 
study). The sonographers had 12 years of  experience in 
abdominal sonography. One of  these sonographers did 
all the scanning for the main study. Spleen sizes were 
measured three times, and the mean values were record-
ed. The measurement of  spleen dimensions was made 
during deep inspiration.
Statistical analysis
Difference of  continuous variables between two inde-
pendent groups was assessed with the Student’s t-test 
while more than two groups were assessed with anal-
ysis of  variance (ANOVA). Intra class correlation co-
efficients (ICCS) were calculated to assess inter- and 
intra rater reliability for ultrasound measurement of  
the spleen, using SPSS statistical package version 10.14 
(SPSS Chicago, Illinois, USA). Statistical significance 
was considered at p < 0.05. Descriptive statistical meth-
ods were used when appropriate.
 
Results
Table 1 shows inter- and intra-variability coefficients in 
the measurement of  spleen length as 0.83 and 0.94 re-
spectively, while those of  spleen width were 0.52 and 
0.76 respectively. 
Table  1:     Intra- and Inter-ratter reliability of Sonographic measurements of spleen size. 
Observer                 Intra- and Inter-Ratter  Reliability (Intra class correlation coefficient at 95% confidence interval) 
                                  Variables       F          lower bound       upper bound              Intra-class correlation values                                  
Intra-observer, 
Sonographer 1           Length          25             0.88                  0.97                       ICC (3, 2, 1) = 0.94                                                                                     
                                  Width           25             0.54                  0.89                         ICC (3, 2, 1) = 0.76                                 
Intra-observer, 
Sonographer 2           Length          25             0.86                  0.95                       ICC (3, 2, 1) = 0.92  
                                  Width           25             0.52                  0.87                         ICC (3, 2, 1) = 0.74                                                                                        
Intra-observer, 
Sonographer 3           Length          25             0.89                  0.98                       ICC (3, 2, 1) = 0.95  
                                  Width           25             0.55                  0.90                         ICC (3, 2, 1) = 0.77                                                                                     
Inter-observer, 
All Sonographers      Length          25             0.70                  0.91                       ICC (3, 2, 1) = 0.83  
                                  Width           25             0.28                  0.73                          ICC (3, 2, 1) = 0.52  
F = Frequency: ICC = Intra class correlation coefficient: 
ICC (3, 2, 1) = Intra class correlation coefficient between the first, second, and third measurements 
obtained by each sonographer, otherwise called intra observer error or variation; and between the first 
measurements obtained by all the sonographers (inter observer error or variation). 
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Table 2 shows matched demographic features of  all the study subjects. 
Table  2: Demographic characteristics of the subjects (HbSS, HbSC & HbAA) 
                                                               Stable SCD Patients                     Healthy HbAA Controls 
Variables                                         Frequency                  %                   Frequency                       %    
AG (years)     2 - 6                           17                               16.50                  17                               16.50 
                      7 - 11                         20                              19.42                  19                               18.45 
                      12 - 16                       13                               12.60                  14                               13.59 
                      17 - 21                       13                               12.60                  13                               12.60 
                      22 - 26                       19                               18.45                  18                               17.48 
                      27 - 31                       8                                 7.80                    8                                 7.80 
                      32 and above             13                               12.60                  14                               13.59 
                      Total                          103                             100.00                103                            100.00      
Sex                Male                          48                               46.60                  56                               54.40 
                      Female                       55                               53.40                  47                               45.60 
                      Total                          103                                 100.00                   103                               100.00   
                                                                                                                                          
MS                Single                        97                               94.20                  94                               91.30       
                      Married                     6                                 5.80                     9                                8.70 
                      Total                          103                             100.00                103                            100.00 
                  
Gt.                 HbSC                         2                                1.90                     -                                  - 
                      HbSS                         101                             98.10                  -                                  -   
                      HbAA                          -                                 -                        103                            100.00                                    
                      Total                         103                             100.00                103                            100.00 
AG (years) =Age groups in years: Gt = Genotype : MS = Marital Status 
HbSC = Compound Heterozygous Sickle Haemoglobin SC:    
HbSS= Homozygous Sickle Haemoglobin SS  or Sickle Cell Anaemia:       
HbAA=   Homozygous Haemoglobin AA  or the Normal Genotype:SCD   =   Sickle Cell Disease. 
Table 3 shows the incremental variation of  spleen sizes 
across the age groups in the control subjects, and an 
undulating variation in spleen sizes in the SCD subjects. 
Generally, the mean spleen length in SCD subjects was 
97.67 ± 39.61 mm, while that of  the control subjects 
was 80.84 ± 16.89 mm. Mean spleen width in SCD sub-
jects was 47.28 ± 20.68 mm, and that of  the control 
subjects was 39.38 ± 9.39 mm. 
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Table 4 shows negative correlation between mean 
spleen sizes and age (r = -0.13), height (r = -0.17), and 
weight (r = -0.06) among SCD subjects, whereas there 
Table  3: Mean spleen sizes of the sickle cell disease patients by age compared with those of the 
controls. 
   
  
AGC in years     Gs.         
Spleen Length in Centimeter Spleen Width in Centimeter 
F          M          SD           
t-v          P-v                             
F          M          SD           
t-v          P-v                             
2 - 6                  SCD     
Versus                                                 
2 - 6                  HbAA 
17      85.35     19.52        
5.82       0.00                
17      55.53     8.08                                
17      43.00      9.73         
5.76       0.00                
17      26.71      6.42         
7 - 11                SCD 
 versus                                 
7 - 11                HbAA            
20      113.95    37.37       
5.04       0.00                      
19    70.90      7.65         
20      53.60      16.57       
4.50       0.00                
19      35.84      5.93             
12 - 16              SCD         
versus                                    
12 - 16              HbAA           
12      113.50    41.11       
3.11       0.01                
14     78.93      6.92         
12      54.58      23.67       
2.84    0.02               
14      36.21      4.92         
17 - 21              SCD           
versus                                    
17 - 21              HbAA            
11      90.45      49.12      
 -0.03       0.98                
13    90.85      12.90      
11      42.27      24.12      
-0.02   0.99                 
13      42.38      3.84         
22 - 26              SCD            
versus                                   
22 - 26              HbAA                          
10      94.20      47.79      
 -0.04        0.98                
18 94.67     8.73        
10      46.90      28.54       
 0.01   0.99              
18      46.83      6.27         
27 - 31              SCD  
versus                                     
27 - 31              HbAA  
            
5        59.80      26.40     
-3.23       0.04                  
8        94.00      11.93 
 
5        27.40      17.07      
-3.18    0.04               
8          49.38      8.00    
 
32 and above    SCD             
Versus                                               
32 and above    HbAA     
 
4        97.00      40.64       
0.41    0.84                  
14      92.43      9.83      
 
4        51.50      26.21       
0.92       0.64                
14      44.64      7.25 
 
AGC = Age groups being compared.  Gs =  Genotype status. F= Frequency     
M= Mean: SD = Standard Deviation: t-v = t-value: P-v =     P-value AGC = Age groups being compared.  Gs =  Genotype status. F= Frequency     
M= Mean: SD = Standard Deviation: t-v = t-value: P-v =     P-value 
HbAA=  Homozygous Haemoglobin AA  or the Normal Genotype  
SCD   =   Sickle Cell Disease 
was positive correlation between mean spleen sizes and 
age (r = 0.63), height (r = 0.85), and weight (r = 0.83) in 
the control subjects. There were no variations of  spleen 
sizes with sex in either group of  subjects (P > 0.05). 
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Table 4: Comparison of the effects of age, height, and weight on the spleen sizes of the 






Variables       
Genotype 
  
Age in years                
  
Height in Centimeter(cm) 
  
Weight in kilogram(Kg) 
  
  
r-value     P-value    
Res.    
  
r-value     P-value    Res.    
  
r-value     P-value    Res. 
    
  
  
Spleen              
SCD  
                   
Length                             
                         
HbAA                
  
  
-0.14         0.23        NS 
  
                                        
0.67          0.00          S                                         
  
  
-0.15         0.18         NS 
  
                                         
0.90 0.00   S                                          
  
  
-0.08         0.50        NS 
  
                                          
0.87          0.00           S 
  
                                              
  
  
Spleen              
SCD     
            
Width                               
                         
HbAA                 
  
  
-0.12         0.29         NS 
  
                                        
0.60          0.00          S                                       
  
  
-0.19         0.09         NS 
  
                                         
0.80 0.00    S                                              
  
  
-0.05         0.69          NS 
  
                                         
0.79          0.00            S 
  
                                                     
Res.= Results.:  NS= Not Significant.:  S= Significant. 
HbAA= Homozygous Haemoglobin AA or the Normal Genotype.  
SCD = Sickle Cell Disease. 
Table 5 shows 8.74 % normal spleen parenchyma, 21.36 
% fibrotic scar littered parenchyma, 2.91%  infarction/
abscess littered parenchyma, 4.85% calcification littered 
parenchyma, 19.42% fine hyper echoic parenchyma and 
19.42 % coarse hyper echoic parenchyma among the 
SCD subjects, while normal spleen parenchyma was 
visualized in all the control subjects.
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Figure 1 shows the trends of  the spleen sizes (spleen 
Table 5: Characterization of the spleen parenchymal echo texture in the sickle cell disease patients.  
F =  Frequency.  :   % = Percentage. :  32+ = 32 years and above. 





                                                          Age Ranges in Years 
2      -     6       7    -   11 12  -  16 17  -  21 22  -  26 27  -  31 32 + Total 
F          %    F         % F         % F         % F         % F         % F         % F         % 
Normal 4      3.88 4      3.88 1      0.97 -          - -          - -          - -          - 9        8.74 
Coarse hyper 
echoic 
1      0.97 
  
7      6.80 
  
4      3.88 
  
3      2.91 
  
2      1.94 
  
1      0.97 
  
2      1.94 
  




9      8.74 
  
4      3.88 
  
3      2.91 
  
2      1.94 
  
1      0.97 
  
-           - 
  
1      0.97 
  




-          - 
  
-          - 
  
3      2.91 
  
6      5.83 
  
4      3.88 
  
2      1.94 
  
1      0.97 
  





-          - 
  
  
1      0.97 
  
  
-          - 
  
  
-          - 
  
  
2      1.94 
  
  
-          - 
  
  
-          - 
  
  





-          - 
  
-          - 
  
1      0.97 
  
3      2.91 
  
4      3.88 
  
3      2.91 
  
-          - 
  




              103   100 
length and spleen width) of  the SCD subjects and those 
of  the controls compared.
Figure  1: Comparison of the trends of the overall spleen sizes (spleen length and spleen width) of 
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Discussion 
Variations in splenic size and parenchyma echo-tex-
ture of  sickle cell disease (SCD) patients exist in the 
literatures reviewed due to differences in race, haplo-
type, ethnicity and clime.12,13,15,17,18 Consequently, some 
authors opined the need to establish population spe-
cific normal abdominal organ morphology in different 
climes and ethnicities.6,11,14 Measurement of  the spleen 
by a competent sonographer using a high quality ultra-
sound machine and proper technique is reliable. This 
is shown by the low inter- and intra-observer errors of  
the pilot study (P > 0.05). This finding agrees with the 
result of  a previous study.14  
In this study, the spleen of  SCD subjects generally had 
undulating variations in size increasing rapidly from 2 
years of  age to the childhood/adulthood transitional 
age of  18 years. Beyond 18 years, there was a mixture 
of  sharp reduction and increase in spleen size in an 
undulating form up to the age of  58 years. Maximum 
numbers of  shrunken spleen and auto-splenectomy 
were recorded between 18 years and 33 years age in this 
study. This implies that, in our locality, the spleen of  
patients with SCD increases rapidly in size from early 
age and peaks at 18 years, and generally declines sharp-
ly to either a shrunken state or auto-splenectomy. This 
trend contradicts the findings of  previous authors12,13,15- 
17 probably because of  differences in study protocol, 
clime and haplotype. It can also be related to high ma-
laria endemicity and frequent bacterial infections that 
may cause hypertrophy and hyperplasia of  the spleen 
in our environment. However, the trend of  spleen sizes 
across the age groups in the control subjects is incre-
mental or gradual in form from early age with a peak 
at 30 years in the present study. This concurs with the 
finding of  Okoye et al11 in a similar population.
 
The mean spleen sizes of  SCD patients were generally 
larger than those of  the controls (P < 0.05), specifically 
in children (age range 2 - 17 years). This could be due 
to low body immunity in this age range with resultant 
high susceptibility of  SCD subjects to the acute compli-
cations of  sickle cell condition. This result agrees with 
the findings of  previous works12,16,21 possibly because of  
similarity in study protocol, but disagrees with the work 
of  Babadoko et al13  in Zaria, Nigeria.
Many authors,13,14,18,20-24 are of  the opinion that a simple 
single measurement of  spleen length is an accurate es-
timate of  spleen size as it correlates strongly with the 
actual spleen dimensions (spleen length, volume and 
weight) at autopsy. Compared with spleen width in the 
present study, the spleen length showed the highest 
correlation with the body parameters. There is negative 
correlation between spleen length and age (P = 0.23; r 
= -0.14), height (P = 0.18; r = -0.15), and weight (P = 
0.50; r = -0.08) among SCD subjects. This is consistent 
with the findings of  other previous authors.18,20 Howev-
er, this contradicts the findings of  significant correlation 
between age and spleen sizes by other researchers16,17,21 
which could be as a result of  differences in ethnicity, 
clime and haplotype. There is positive correlation be-
tween mean spleen sizes and age (P = 0.00, r = 0.67), 
height (P = 0.00, r = 0.90), and weight (P = 0.00, r = 
0.87) in the control subjects. These findings are consist-
ent with the findings of  other scholars.11, 14,18,21,23-25 
In the present study, auto-splenectomy was detected in 
23.30% of  SCD subjects, while shrunken spleen was 
found in 10.86% of  the SCD subjects. These are statis-
tically smaller (P < 0.05) than those of  other previous 
works13,26-28 but are significantly larger (P < 0.05) than 
those of  other authors.15,17 However, they concur with 
the findings of  Awotua-Efebo et al12 in children popu-
lation in Port Harcourt, Nigeria. Interestingly, our study 
included more paediatric subjects. Mild splenomega-
ly, moderate splenomegaly and massive splenomegaly 
were seen in 4.85%, 12.62% and 15.53% of  the SCD 
subjects respectively in the current study. The threshold 
for mild splenomegaly is defined at one standard devi-
ation (SD) above the average spleen size in the healthy 
population while the massive splenomegaly threshold 
is defined at two SD above the average spleen size in 
the healthy population.29 Moderate splenomegaly values 
are values between the upper limit and lower limits of  
mild and massive splenomegaly respectively as defined 
above.  Generally, a total of  33.01% cases of  spleno-
megaly were found in the present study. They are sta-
tistically larger (P < 0.05) than those recorded by other 
related works.12,13,17,22,27 This may be because the present 
study included more paediatric patients. However, the 
splenomegaly cases in the present study are significantly 
lower (P < 0.05) than the findings of  other authors in 
an Indian15 and Greek28 populations. 
A significant number of  SCD subjects studied in this 
work had their spleen persisting into adult ages with 
consequent anomalous spleen parenchyma. Thus, we 
found 8.74% normal parenchyma, 19.42% coarse hy-
per echoic parenchyma, and 19.42% fine hyper echoic 
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parenchyma in the SCD subjects. Others are 15.53% 
fibrotic scar littered parenchyma, 2.91% infarction/ab-
scess littered parenchyma and 10.68% calcification lit-
tered parenchyma. Splenic calcifications in the current 
study were also both punctuate and amorphous among 
the SCD subjects. 
Splenic infarction and abscess are difficult to differenti-
ate by sonography alone; hence, they were characterized 
together as infarction/abscess littered parenchyma in 
the present study. The frequency of  infarction/abscess 
littered parenchyma in the present study is too small 
relative to the findings of  Mohanty et al15 probably be-
cause they studied SCD subjects in crisis state while the 
present study was on stable SCD subjects. The inci-
dence of  calcification littered parenchyma in this study 
concurs with the findings of  others.15 This could be as 
a result of  similarity in the age range of  SCD subjects 
studied. The findings of  the present study regarding in-
farction/abscess and calcification littered parenchyma 
significantly differed from a previous report in a Turk-
ish population.22  
Limitations of  the study 
Illiteracy and ignorance of  most sickle cell disease pa-
tients and their guardians affected the data collection. A 
lot of  time was spent explaining the nature and essence 
of  this study to most of  the SCD patients and their 
guardians before they gave their consent to participate. 
The study was of  limited size and conducted at only 
1 site.  The subjective differences in the parenchyma 
echo-texture classification were not determined in this 
study.    
Conclusion 
The results of  this study suggest inclusion of  routine 
sonographic study of  the spleen size and parenchyma 
echo-texture in the management of  SCD patients.  
Recommendations  
1. Abdominal ultrasound investigation may be used 
to detect splenic infarction or splenic abscess, based 
on the size of  the spleen and the splenic parenchyma 
echo-texture, in the sickle cell disease patients. 
2. Routine abdominal sonographic examination should 
be made part of  the clinical care given to all sickle cell 
disease patients.
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